Peter Mattingly

Dr. Peter Mattingly

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2026 in Annals of Internal Medicine: Clinical Cases
Verified
Journal Article
Closed access
TPTirth Patel
Tirth Patel
SKSumanth Khadke
Sumanth Khadke
JTJames Thomas
James Thomas
Peter MattinglyPeter Mattingly
Peter Mattingly

31 July 2026 in BMJ Neurology Open
Verified
Journal Article
Open access
PDF file
JLJoão Pedro Lima
João Pedro Lima
LMLawrence Mbuagbaw
Lawrence Mbuagbaw
MPManya Prasad
Manya Prasad
AKAmit Kumar
Amit Kumar
GWGuy Sadeu Wafeu
Guy Sadeu Wafeu
Gordon GuyattGordon Guyatt
Gordon Guyatt
Objectives: In patients living with advanced dementia, the intensity of care during life-threatening infections remains controversial and marked by wide variation in practice. This international survey investigated physicians’ and physicians-in-training’s management choices for individuals with advanced dementia and the factors associated with those choices. Design: Vignette-based survey. Setting: Twelve countries across five continents. Methods: We administered our vignette-based survey to medical students, residents and physicians. The survey elicited participants’ views on whether antibiotics should be administered to an elderly patient with advanced dementia and very poor quality of life, presenting with bacterial pneumonia. We explored factors associated with treatment choices using univariable analysis and multiple logistic regression models. Results: Of the 785 participants (age, mean (SD): 31.1 (11.5) years), one-third (31.2%) resided in the Region of the Americas, 21.9% in Europe, 16.2% in the Eastern Mediterranean region and 17.1% in China. In the univariable analysis, choice to treat was associated with younger age, country/WHO region (African region highest overall, European region lowest overall), stage of medical training (medical student most inclined to treat) and absence of medical assistance in dying (MAiD) legislation. Multivariable analyses provided evidence that country was the variable most strongly associated with the choice to treat with antibiotics (Cameroon, China, Saudi Arabia highest; Norway, Switzerland, Spain lowest), with the presence of MAiD legislation also strongly associated (OR 0.35, 95% CI 0.23 to 0.51). Age (OR 0.82, 95% CI 0.66 to 1.00) and religiosity level (OR 0.93, 95% CI 0.87 to 0.99) showed weaker associations with treatment decisions. Conclusion: Inclination to treat individuals with advanced dementia who develop pneumonia varies greatly between and within jurisdictions. Social factors (in particular country but also presence of MAiD legislation) proved the most prominent associations, with individual characteristics much less influential. These findings underscore the importance of contextual and cultural factors in value-sensitive clinical decisions. Registration: We registered the protocol at Open Science Framework (osf.io/6kfbt).

20 June 2026 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
AGAleksandar Gavrancic
Aleksandar Gavrancic
CJChristian Michael Jacobson
Christian Michael Jacobson
VRVeljko Rabasovic
Veljko Rabasovic
ESErik Sviggum
Erik Sviggum
JSJelena Stojsavljevic
Jelena Stojsavljevic
Igor DumicIgor Dumic
Igor Dumic
Background: Anaplasmosis is an emerging tick-borne infection that typically presents as a non-specific febrile illness, with variable degrees of cytopenias and liver tests abnormalities. Severe complications remain atypical and uncommon. Case Report: We report a case of acute pulmonary embolism (PE) occurring during confirmed anaplasmosis in a 73-year-old male with no traditional thromboembolic risk factors. The patient presented with fever, constitutional symptoms, thrombocytopenia, leukopenia, and abnormal liver tests, raising suspicion for a tick-borne illness. Despite early clinical improvement on doxycycline, persistent tachycardia triggered further evaluation and uncovered an acute PE. Comprehensive workup at admission and repeated 14 months later excluded inherited and acquired thrombophilias, malignancies, autoimmune diseases, and alternative infectious etiologies. The patient was treated with doxycycline 100 mg orally twice daily for 10 days and anticoagulation with unfractionated heparin followed by 6 months of apixaban for a first episode of provoked PE. He attained complete clinical recovery without recurrence of thrombosis at the two-year follow-up. Discussion: Infectious diseases are increasingly recognized as contributors to thrombosis through inflammation-mediated hypercoagulability and endothelial dysfunction. Pulmonary involvement in anaplasmosis typically manifests as pneumonitis, pneumonia or acute respiratory distress syndrome, but thrombotic complications such as PE are exceedingly rare. This case highlights a rare but clinically significant vascular complication of anaplasmosis and underscores the importance of considering thromboembolic events in patients with persistent or unexplained tachycardia. Conclusions: As the incidence of anaplasmosis continues to rise, greater awareness of its potential cardiovascular manifestations is essential. Early recognition and prompt treatment with doxycycline remain critical, while further studies are needed to better define the thrombotic risk associated with this infection.

10 July 2026 in Journal of Hospital Medicine
Verified
Journal Article
Closed access
PDF file
Peter MattinglyPeter Mattingly
Peter Mattingly
IMIfeanyi Momodu
Ifeanyi Momodu
BKBrian Kwan
Brian Kwan
JWJoyanna Wendt
Joyanna Wendt
NCNaveed Choudry
Naveed Choudry